These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 37771166)

  • 1.
    S V N; B S C; Mahesha ; K N CP; M K H; N K L
    J Biomol Struct Dyn; 2023 Sep; ():1-21. PubMed ID: 37771166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 Mpro binding profile and drug-likeness of two novel thiazole derivatives: structural elucidation, DFT studies, ADME-T and molecular docking simulations.
    Tumakuru Nagarajappa L; Ravi Singh K; Kabuyaya Isamura B; Vinay Kumar KS; Mandayam Anandalwar S; Sadashiva MP
    J Biomol Struct Dyn; 2023 Dec; 41(20):11122-11136. PubMed ID: 36576177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and crystal structures of new mixed-ligand schiff base complexes containing
    Ghasemi L; Hasanzadeh Esfahani M; Abbasi A; Behzad M
    Polyhedron; 2022 Jul; 220():115825. PubMed ID: 35399322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virtual screening, ADMET prediction and dynamics simulation of potential compounds targeting the main protease of SARS-CoV-2.
    Yadav R; Imran M; Dhamija P; Chaurasia DK; Handu S
    J Biomol Struct Dyn; 2021 Oct; 39(17):6617-6632. PubMed ID: 32715956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of potential inhibitors against
    Gaur V; Kumar N; Vyas A; Chowdhury D; Singh J; Bera S
    J Biomol Struct Dyn; 2023 Dec; ():1-11. PubMed ID: 38149858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An In silico Investigation to Identify Promising Inhibitors for SARS-CoV-2 M
    Alagarsamy V; Sundar PS; Narendhar B; Sulthana MT; Kulkarni VS; Aishwarya AD; Solomon VR; Murugesan S; Jubie S; Rohitha K; Dhanwar S
    Med Chem; 2023; 19(9):925-938. PubMed ID: 37069723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of some novel oxazine substituted 9-anilinoacridines as SARS-CoV-2 inhibitors for COVID-19 by molecular docking, free energy calculation and molecular dynamics studies.
    Rajagopal K; Varakumar P; Aparna B; Byran G; Jupudi S
    J Biomol Struct Dyn; 2021 Sep; 39(15):5551-5562. PubMed ID: 32720578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New tetrahydroisoquinoline-4-carbonitrile derivatives as potent agents against cyclin-dependent kinases, crystal structures, and computational studies.
    El Bakri Y; Karthikeyan S; Lai CH; Bakhite EA; Ahmad I; Abdel-Rahman AE; Abuelhassan S; Marae IS; Mohamed SK; Mague JT
    J Biomol Struct Dyn; 2024 Jul; 42(10):5053-5071. PubMed ID: 38764131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, crystal structure, and a molecular modeling approach to identify effective antiviral hydrazide derivative against the main protease of SARS-CoV-2.
    Mohamed SK; El Bakri Y; Abdul DA; Ahmad S; Albayati MR; Lai CH; Mague JT; Tolba MS
    J Mol Struct; 2022 Oct; 1265():133391. PubMed ID: 35663190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and molecular dynamics simulation studies of quinoline derivatives as protease inhibitors against SARS-CoV-2.
    Singh VK; Chaurasia H; Kumari P; Som A; Mishra R; Srivastava R; Naaz F; Singh A; Singh RK
    J Biomol Struct Dyn; 2022; 40(21):10519-10542. PubMed ID: 34253149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computational study of novel inhibitory molecule, 1-(4-((2
    Sharma PP; Kumar S; Srivastava S; Srivastava M; Jee B; Gorobets NY; Kumar D; Kumar M; Asthana S; Zhang P; Poonam ; Zoltner M; Rathi B
    J Biomol Struct Dyn; 2022; 40(20):10162-10180. PubMed ID: 34151735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel imidazole-based azo molecule: synthesis, characterization, quantum chemical calculations, molecular docking, molecular dynamics simulations and ADMET properties.
    Karabacak Atay Ç; Dilek Ö; Tilki T; Dede B
    J Mol Model; 2023 Jul; 29(8):226. PubMed ID: 37405575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Copper(II) Schiff base complex derived from salen ligand: structural investigation, Hirshfeld surface analysis, anticancer and anti-SARS-CoV-2.
    Kumar S; Choudhary M
    J Biomol Struct Dyn; 2023 Jul; 41(11):4957-4980. PubMed ID: 35604068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 25 (S)-Hydroxycholesterol acts as a possible dual enzymatic inhibitor of SARS-CoV-2 M
    Alzahrani FA; Alkarim SA; Hawsawi YM; Abdulaal WH; Albiheyri R; Kurdi B; Alguridi H; El-Magd MA
    J Biomol Struct Dyn; 2023 Jul; 41(10):4744-4755. PubMed ID: 35510619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Finding potent inhibitors against SARS-CoV-2 main protease through virtual screening, ADMET, and molecular dynamics simulation studies.
    Roy R; Sk MF; Jonniya NA; Poddar S; Kar P
    J Biomol Struct Dyn; 2022 Sep; 40(14):6556-6568. PubMed ID: 33682642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting SARS-CoV-2 main protease: structure based virtual screening, in silico ADMET studies and molecular dynamics simulation for identification of potential inhibitors.
    Uniyal A; Mahapatra MK; Tiwari V; Sandhir R; Kumar R
    J Biomol Struct Dyn; 2022 May; 40(8):3609-3625. PubMed ID: 33226303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In silico identification of potential inhibitors of key SARS-CoV-2 3CL hydrolase (Mpro) via molecular docking, MMGBSA predictive binding energy calculations, and molecular dynamics simulation.
    Choudhary MI; Shaikh M; Tul-Wahab A; Ur-Rahman A
    PLoS One; 2020; 15(7):e0235030. PubMed ID: 32706783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 liver and gastroenterology findings: An
    Peiter GC; de Souza CBT; de Oliveira LM; Pagliarin LG; Dos Anjos VNF; da Silva FAF; de Melo FF; Teixeira KN
    World J Hepatol; 2022 Jun; 14(6):1131-1141. PubMed ID: 35978663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, spectroscopic, and computational studies on molecular charge-transfer complex of 2-((2-hydroxybenzylidene) amino)-2-(hydroxymethyl) propane-1, 3-diol with chloranilic acid: Potential antiviral activity simulation of CT-complex against SARS-CoV-2.
    Khalil TE; Elbadawy HA; Attia AA; El-Sayed DS
    J Mol Struct; 2022 Mar; 1251():132010. PubMed ID: 34866653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular insights to the binding interactions of APNS containing HIV-protease inhibitors against SARS-CoV-2 M
    Purohit P; Dash JJ; Muya JT; Meher BR
    J Biomol Struct Dyn; 2023 Jun; 41(9):3900-3913. PubMed ID: 35388744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.